397 results on '"Tanosaki R"'
Search Results
2. Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation
3. Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality
4. PBSC collection from family donors in Japan: a prospective survey
5. Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage
6. A higher number of infused CD34+ cells has a positive impact on the clinical outcome after related PBSC transplantation
7. Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer
8. Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study
9. Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study
10. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation
11. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning
12. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma
13. Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome
14. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study
15. Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation
16. Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0
17. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan
18. Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
19. Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor
20. Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)
21. Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan, and antithymocyte globulin: serial comparison with conventional myeloablative transplantation
22. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
23. High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma
24. Primary cutaneous aspergillosis caused by Aspergillus ustus following reduced-intensity stem cell transplantation
25. Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin
26. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation
27. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan
28. Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation
29. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials
30. Decreased insulin secretion in patients receiving tacrolimus as GVHD prophylaxis after allogeneic hematopoietic SCT
31. LONG-TERM FOLLOW UP OF ANTI-HOST A/B ANTIBODY AFTER MINOR ABO-INCOMPATIBLE HEMATOPOIETIC STEM CELL TRANSPLANTATION: 3C-S14-05
32. Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens
33. Guillain–Barre syndrome associated with rapid immune reconstitution following allogeneic hematopoietic stem cell transplantation
34. Hyperacute GVHD and emergence of peripheral CD3+CD56+ T cells and activated natural killer cells are useful markers for early diagnosis of post-transplant hemophagocytic syndrome
35. Endoscopic evaluation for cytomegalovirus enterocolitis after allogeneic haematopoietic stem cell transplantation
36. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intrathecal vancomycin in an allogeneic peripheral blood stem cell transplant recipient
37. Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with HLA-A*02 or HLA-A*24 phenotypes undergoing haematopoietic stem cell transplantation
38. Sinus bradycardia associated with cyclosporine following allogeneic hematopoietic stem cell transplantation
39. γδ T-cell neoplasms: a clinicopathological study of 11 cases
40. Engraftment of normal stem cells in W/Wv mice assessed by a novel quantitative PCR analysis
41. Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality
42. 533 Extended treatment-free interval with excellent life more than two years after autologous dendritic cell vaccine therapy targeting HTLV-1 Tax for previously treated adult T-cell leukemia/lymphoma: The follow-up kinetics of cytotoxic T lymphocytes and HTLV-1 viral load
43. 3228 Cure of adult T-cell leukemia/lymphoma by allogeneic stem cell transplantation with reduced conditioning intensity - End results for the patients who received prospective trials
44. Excellent Quality of Lives for Previously Treated Adult T-Cell Leukemia/Lymphoma Patients After Autologous Dendritic Cell Vaccine Therapy Targeting Htlv-1 Tax Antigens
45. Novel and rapid enumeration method of peripheral blood stem cells using automated hematology analyzer
46. Drug-Drug Interaction Between Tacrolimus and Azole Anti-Fungal Agents, Itraconazole and Voriconazole, in Allogeneic Hematopoietic Stem Cell Transplantation Recipients
47. Prognostic Significance of Pre-Transplantation FDG-PET/CT in Patients Who Undergo Allogenic Stem Cell Transplantation for Lymphoma
48. Relationship Between Clearance of Intravenous Calcineurin Inhibitors and Area Under the Concentration-Time Curve Decreases During the Switch From Continuous Intravenous Infusion to Oral Administration After Allogeneic Hematopoietic Stem Cell Transplantation
49. Day +11 Methotrexate (MTX) Might Reduce the Risk of Engraftment Syndrome (ES) and Acute Graft-Versus-Host Disease (GvHD) After Unrelated Bone Marrow Transplantation (U-BMT) With Reduced-Intensity Conditioning Regimens
50. Cladribine (2CdA) Is Comparable To Fludarabine In A Busulfan-Based Reduced- Intensity Regimen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.